All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F11%3A10099490" target="_blank" >RIV/00216208:11150/11:10099490 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11160/11:10099490

  • Result on the web

    <a href="http://www.sciencedirect.com/science/article/pii/S0024320511004243" target="_blank" >http://www.sciencedirect.com/science/article/pii/S0024320511004243</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.lfs.2011.08.014" target="_blank" >10.1016/j.lfs.2011.08.014</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Modification of hepatic iron metabolism induced by pravastatin during obstructive cholestasis in rats

  • Original language description

    The aim of the study was to evaluate iron biochemistry and contributing liver mechanisms during obstructive cholestasis and pravastatin treatment in rats. A rat model of cholestasis induced by bile duct ligation (BDL) was used for the study. The administration of pravastatin to BDL animals attenuated proliferation changes in liver parenchyma, prevented HO-1 induction, restored hepatic mRNA hepcidin expression to control levels and induced the mRNA expression of ferritin, transferrin receptors (TfR1/2) and divalent metal transporter-1. This was accompanied by an increased content of intrahepatic iron when compared to the BDL animals, and a reduction of hyperbilirubinemia. In conclusion, cholestasis-induced increase in plasma and decrease in hepatic ironlevels were associated with up-regulation of liver HO-1 and ferroportin 1. Pravastatin alleviated cholestatic liver impairment and raised liver iron content by modulation of heme catabolism and an increase of hepatic iron uptake and stor

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FR - Pharmacology and apothecary chemistry

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach

Others

  • Publication year

    2011

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Life Sciences

  • ISSN

    0024-3205

  • e-ISSN

  • Volume of the periodical

    89

  • Issue of the periodical within the volume

    19

  • Country of publishing house

    NL - THE KINGDOM OF THE NETHERLANDS

  • Number of pages

    8

  • Pages from-to

    717-724

  • UT code for WoS article

    000296311800007

  • EID of the result in the Scopus database